SlideShare a Scribd company logo
PRE-MALIGNANT CONDITIONS
AND
MANAGEMENTALGORITHM
FOR
CA. PENIS
Dept of Urology
Govt Royapettah Hospital and Kilpauk Medical College
Chennai
1
Moderators:
Professors:
 Prof. Dr. G. Sivasankar, M.S., M.Ch.,
 Prof. Dr.A. Senthilvel, M.S., M.Ch.,
Asst Professors:
 Dr. J. Sivabalan, M.S., M.Ch.,
 Dr. R. Bhargavi, M.S., M.Ch.,
 Dr. S. Raju, M.S., M.Ch.,
 Dr. K. Muthurathinam, M.S., M.Ch.,
 Dr. D.Tamilselvan, M.S., M.Ch.,
 Dr. K. Senthilkumar, M.S., M.Ch.
Dept of Urology, GRH and KMC,Chennai. 2
3
Premalignant Lesions
HPV RELATED Related Lesions
Cutaneous horns
Bowenoid Papulosis
Bowen’s Disease
Erythroplasia of Queyrat
Giant Condylomata Acuminata
(Buschke-Lowenstein Tumour)
Dept of Urology, GRH and KMC,Chennai.
NON HPV RELATED
Leukoplakia
Pseudoepitheliomatous Micaceous Keratotic Balanitis (PMKB)
Balanitis Xerotica Obliterans (Lichen scleorus et Atrophicus)
4
Dept of Urology, GRH and KMC,Chennai.
5
Penile Intraepithelial Neoplasia (PeIN)
 Precursor lesion of basaloid & warty penile cancer
 HPV infection asso. with all types of PeIN (70-100%)
 Basaloid cancer  strongest asso. with HPV (70-100%)
 PeIN in males whose female partner has CIN = 33%
 Time for malignant progression for low-grade PeIN = 20 yrs
World J Urol 2009;27(2):141–50
Urol Clin N Am 2010; 37: 335–32
Dept of Urology, GRH and KMC,Chennai.
6
Bowenoid Papulosis
 HPV-related 16 & 18
 Average age 30 yrs
 Majority (73%) regress or do not recur
 Can recur, progress to EQ or BD,or become
malignant
 Strong relationship with CIN in female sexual
partners
 Microscopy:spotty distribution of atypical
cells & greater maturation of keratinocytes
 Risk factors for malignant progression
◦ Smoking, immune suppression, high-risk
HPV types, genetics
Dept of Urology, GRH and KMC,Chennai.
7
Bowen’s Disease/Erythroplasia of Queyrat
 EQ= glans, prepuce
 BD= Hair bearing region of
genitalia/shaft of penis.
 Both histologically similar- correspond
toTis
 Clearly documented as precursors of
invasive penile carcinoma = 10% risk
Dept of Urology, GRH and KMC,Chennai.
8
Lichen Sclerosis et Atrophicus (BXO)
 Whitish patch on prepuce/glans often
involving meatus
 Granular erosions,fissures, meatal
stenosis, painful erections, urinary
obstruction
 Uncircumcised middle age men
 Microscopy:
◦ Atrophy of squamous epithelium, loss of rete
pegs, homogenisation of collagen in upper 1/3rd
of dermis
 Clobetasol propionate (0.05% , 8–12 wks)
Dept of Urology, GRH and KMC,Chennai.
9
Giant Condyloma Accuminata
 Buschke-LowensteinTumour
 Locally invasive; displaces, invades &
destroys adjacent structures by
compression
 No metastasis
 LN mets: Rare => malignant degn
 Excision/total Penectomy
 Topical 5FU, podophyllin, Bleomycin
 RT – ineffective & contraindicated 
Malignant Degeneration
Dept of Urology, GRH and KMC,Chennai.
10
Verrucous Carcinoma
•Is an exuberant variant of sq. cell carcinoma
•Low malignant potential
•Rarely metastasize to lymphnode
•Good prognosis
Dept of Urology, GRH and KMC,Chennai.
11
Cutaneous Horn
- Overgrowth & Cornification over
preexisting skin lesions
- Asso with HPV 16
-May evolve into Cancer or develop in an
underlying Cancer
- Surgical Excision
Pseudo epitheliomatous keratotic
& micaceous balanitis (PKMB)
- Microscopically mimics verrucous Cancer
- Cryotherapy,laser, excision
- Fibro sarcoma of glans post Cryotherapy
Dept of Urology, GRH and KMC,Chennai.
Leukoplakia
•Solitary or multiple whitish plaques
•Involving glans, prepuce, meatus
•Asso.withTis and Ta
- Surgical Excision
12
Dept of Urology, GRH and KMC,Chennai.
13
Lesions with No malignant Potential
 Pearly penile papules
 Hirsute papillomas
 Coronal Papillae
 Zoon’s Balanitis
 Benign pigmented warts
 Seborrheic keratosis
 Lichen planus
 Psoriasis
 Eczema
 Contact dermatitis
Dept of Urology, GRH and KMC,Chennai.
14
Treatment of Premalignant lesions
eradicate disease while limiting penile mutilation
 TopicalTreatment: (Recurrence:13–19%)
◦ Podophyllotoxin, 5 - FU,Imiquimod, Corticosteroids,Trichloracetic
acid
 Ablative treatments:
◦ Cryosurgery (Recurrence:21%)
◦ Electro surgery
◦ Laser - Nd-YAG, KTP 532, CO2 Lasers (Recurrence:0 -33%)
Dept of Urology, GRH and KMC,Chennai.
ExcisionalTreatments: (Recurrence 13-33%)
Excision Biopsy
Moh’s Micrographic Surgery
Excision + total glans resurfacing
Radiotherapy/ IFNs
15
Dept of Urology, GRH and KMC,Chennai.
16
Treatment of Premalignant lesions
Urology 2010;76 (Suppl 2A): S24 –S35
Dept of Urology, GRH and KMC,Chennai.
17
Histopathology
 Histologic evaluation – “ is Must”
 Wedge biopsy is preferable for diagnosis
◦ Histologic type & grade
◦ Depth of invasion
◦ Vascular invasion
◦ Treatment decisions & Prognosis - preferably based on resected specimen
 Good pathology report
◦ Anatomic site, tumor size, histologic type or subtype
◦ Grade, growth pattern
◦ Depth of invasion, tumor thickness, resection margins
◦ Lympho vascular invasion, perineural invasion
Dept of Urology, GRH and KMC,Chennai.
18
Ca. Penis
Management of Primary
Organ Conservation
Standard Surgical Procedures
Partial penectomy
Total penectomy
Emasculation
Dept of Urology, GRH and KMC,Chennai.
Organ Conserving Surgical Approach
 LaserTherapy
 Mohs Micrographic Surgery
 Conservative Local Surgical Excision
◦ Circumcision
◦ Local excision
◦ Total glansectomy
19
Dept of Urology, GRH and KMC,Chennai.
LaserTherapy
 Lasers used 
 carbon dioxide (CO2),
 neodymium:yttrium-aluminum-garnet (Nd:YAG)
 potassium titanyl phosphate (KTP)
 Drawbacks
◦ Healing time - 5 to 8 weeks for CO2 laser (8 to 12
weeks for the Nd :YAG and KTP lasers)
◦ local recurrence rate – 20%
◦ difficulty in determining depth of laser coagulation
◦ inability to treat larger lesions
◦ careful long-term surveillance
20
Dept of Urology, GRH and KMC,Chennai.
Mohs Micrographic Surgery
 removal of cancer by excision of tissue in
thin layers
 Local control rate - 94%
 Best suited in- Ca.in situ, smallT1
21
Dept of Urology, GRH and KMC,Chennai.
Local excision
 excision of lesion with negative margin
 Reconstruction
 primary closure,
 preputial skin flap,
 full-thickness graft of penile skin ,
 SSG
 local recurrence - 8% to 11%
22
Dept of Urology, GRH and KMC,Chennai.
Treatment of Primary lesion-Ta
 Laser Excision
 Mohs
Micrographic
Surgery
 RT
-
contraindicated
23
Dept of Urology, GRH and KMC,Chennai.
Treatment of Primary lesion- Options
 T1,T2,T3 
◦ Partial penectomy
◦ Total penectomy
◦ Emasculation
24
Dept of Urology, GRH and KMC,Chennai.
Treatment of Primary lesion- Options
 T4
◦ Emasculation
◦ Hemipelvectomy
25
Dept of Urology, GRH and KMC,Chennai.
Penile Cancer
Predictors of lymph node metastases
 Tumour histology
 Corporal invasion
 Urethral involvement
 Tumour grade
 Lymphatic & vascular invasion
 DNA ploidy
26
Dept of Urology, GRH and KMC,Chennai.
MANAGEMENT OF INGUINAL NODES
CA.PENIS
SURGERY
IF PALPABLE NODES
ANTIBIOTICS
(4-6WEEKS)
27
Dept of Urology, GRH and KMC,Chennai.
NODES NOT PALPABLE NODES PALPABLE
PRIMARY – WELL-DIFF NODAL METS
OBSERVE ILIO-INGUINAL BLOCK
DISSECTION
IF PRIMARY MOD/POOR DIFF
SUPERFICIAL LND
NODE NEG – OBSERVE
IF NODE POSITIVE
28
Dept of Urology, GRH and KMC,Chennai.
Radiation Therapy for
the Primary Lesion
 Indications
◦ young patients with small (2- to 4-cm)
superficial lesions of distal penis, not willing
for amputation
◦ patients who refuse surgery
◦ patients with inoperable cancer
◦ Patients unsuitable for major surgery.
29
Dept of Urology, GRH and KMC,Chennai.
Radiation Therapy for
the Primary Lesion
 EBRT 
◦ direct field method - only for very superficial
tumors (Tis ,T1)
◦ parallel opposed field method - T2,T3 (penis
irradiated by encasing the lesion in a wax
mold)
 Brachytherapy 
◦ Interstitial brachytherapy - placement of
radioactive material within the tumor
◦ Plesiobrachytherapy- placement of
radioactive material molded around the
tumor
30
Dept of Urology, GRH and KMC,Chennai.
Brachytherapy not suitable
 bulky tumors
 obese patients with short penis
 deeply infiltrating tumors
31
Dept of Urology, GRH and KMC,Chennai.
Radiation Therapy for
the Primary Lesion
 60 Gy to 74 Gy
 Salvage penectomy
◦ persistent or recurrent disease after RT
◦ radiation necrosis
32
Dept of Urology, GRH and KMC,Chennai.
Although cosmetically attractive, disadvantages
are
◦ Useful only in early stage (T1,T2)
◦ Only 65-80% success rate even in early stage
◦ Penile necrosis - 0% to 23%
◦ High chance for stricture urethra
◦ Penectomy required for recurrence and necrosis
33
Dept of Urology, GRH and KMC,Chennai.
Role of radiotherapy
 Radiation to the inguinal area is not as effective as
surgery for treatment of the inguinal nodes.
 Prophylactic radiation therapy has not been shown to
alter the natural history of inguinal metastases and
is not recommended.
 Integration of radiation therapy with surgery and
chemotherapy in advanced disease requires further
study.
 Palliative radiation therapy among patients with
inoperable
inguinal nodes may provide some benefit.
34
Dept of Urology, GRH and KMC,Chennai.
Relative Indications for adjuvant
therapy- Chemotherapy, RT
 >2 metastatic inguinal nodes
 Extranodal extension of disease
 Pelvic lymph node metastases
35
Dept of Urology, GRH and KMC,Chennai.
36
Inguinal Nodes- Surgical Staging
Nomograms to predict inguinal LNM
KATTAN, FICCARO ETAL.
◦ tumor thickness,
◦ microscopic growth pattern,
◦ histologic grade,
◦ Vascular embolization,
◦ lymphatic embolization,
◦ infiltration of corpora cavernosa,
◦ corpus spongiosum, or urethra,&
◦ clinical stage of inguinal lymph nodes
Dept of Urology, GRH and KMC,Chennai.
ThankYou
37
Dept of Urology, GRH and KMC,Chennai.

More Related Content

What's hot

Seminoma
SeminomaSeminoma
Premalignant penile lesions.pptx
Premalignant penile lesions.pptxPremalignant penile lesions.pptx
Premalignant penile lesions.pptx
Rabindra Tamang
 
Desmoid final
Desmoid finalDesmoid final
Desmoid final
Sameer Rastogi
 
Sentinal lymph node biopsy
Sentinal lymph node biopsySentinal lymph node biopsy
Sentinal lymph node biopsy
Jamil Kifayatullah
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
Isa Basuki
 
Management Of Testicular Tumours
Management Of Testicular TumoursManagement Of Testicular Tumours
Management Of Testicular Tumoursfondas vakalis
 
Ca penis
Ca penis Ca penis
Ca penis
Nilesh Kucha
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
Kiran Ramakrishna
 
CA Prostate
CA ProstateCA Prostate
CA Prostate
DrAyush Garg
 
Bladder carcinoma
Bladder carcinomaBladder carcinoma
Bladder carcinoma
Jyotindra Singh
 
Sentinel lymph node breast ca
Sentinel lymph node breast caSentinel lymph node breast ca
Sentinel lymph node breast ca
Pannaga Kumar
 
Retroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushalRetroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushal
yadavkaushal
 
Phyllodes tumor
Phyllodes tumorPhyllodes tumor
Phyllodes tumor
Shambhavi Sharma
 
Pre malignant lesions of skin
Pre malignant lesions of skinPre malignant lesions of skin
Pre malignant lesions of skin
Saikat Mandal
 
Ca rectum
Ca rectumCa rectum
Ca rectum
syed ubaid
 
In the Flesh- dermatofibrosarcoma protuberans (dfsp)
 In the Flesh- dermatofibrosarcoma protuberans (dfsp) In the Flesh- dermatofibrosarcoma protuberans (dfsp)
In the Flesh- dermatofibrosarcoma protuberans (dfsp)
Tony L. Weaver, D.O.
 
Carcinoma rectum (Rectal Cancer)
Carcinoma rectum (Rectal Cancer)Carcinoma rectum (Rectal Cancer)
Carcinoma rectum (Rectal Cancer)
Dr Vandana Singh Kushwaha
 
Penis carcinoma- overview
Penis  carcinoma- overviewPenis  carcinoma- overview
Penis carcinoma- overview
GovtRoyapettahHospit
 

What's hot (20)

Seminoma
SeminomaSeminoma
Seminoma
 
Premalignant penile lesions.pptx
Premalignant penile lesions.pptxPremalignant penile lesions.pptx
Premalignant penile lesions.pptx
 
Desmoid final
Desmoid finalDesmoid final
Desmoid final
 
Sentinal lymph node biopsy
Sentinal lymph node biopsySentinal lymph node biopsy
Sentinal lymph node biopsy
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 
Management Of Testicular Tumours
Management Of Testicular TumoursManagement Of Testicular Tumours
Management Of Testicular Tumours
 
Ca penis
Ca penis Ca penis
Ca penis
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 
CA Prostate
CA ProstateCA Prostate
CA Prostate
 
Bladder carcinoma
Bladder carcinomaBladder carcinoma
Bladder carcinoma
 
Sentinel lymph node breast ca
Sentinel lymph node breast caSentinel lymph node breast ca
Sentinel lymph node breast ca
 
Retroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushalRetroperitoneal lymph node dissection kaushal
Retroperitoneal lymph node dissection kaushal
 
Phyllodes tumor
Phyllodes tumorPhyllodes tumor
Phyllodes tumor
 
Pre malignant lesions of skin
Pre malignant lesions of skinPre malignant lesions of skin
Pre malignant lesions of skin
 
Testicular tumours
Testicular tumoursTesticular tumours
Testicular tumours
 
Ca rectum
Ca rectumCa rectum
Ca rectum
 
In the Flesh- dermatofibrosarcoma protuberans (dfsp)
 In the Flesh- dermatofibrosarcoma protuberans (dfsp) In the Flesh- dermatofibrosarcoma protuberans (dfsp)
In the Flesh- dermatofibrosarcoma protuberans (dfsp)
 
GLEASON SCORING
GLEASON SCORINGGLEASON SCORING
GLEASON SCORING
 
Carcinoma rectum (Rectal Cancer)
Carcinoma rectum (Rectal Cancer)Carcinoma rectum (Rectal Cancer)
Carcinoma rectum (Rectal Cancer)
 
Penis carcinoma- overview
Penis  carcinoma- overviewPenis  carcinoma- overview
Penis carcinoma- overview
 

Similar to Penis carcinoma- premalignant and management algorithm

Non muscle invasive bladder carcinoma - management
Non muscle invasive bladder carcinoma - managementNon muscle invasive bladder carcinoma - management
Non muscle invasive bladder carcinoma - management
GovtRoyapettahHospit
 
Upper urinary tract - Urothelial cell carcinoma
Upper urinary tract - Urothelial cell carcinomaUpper urinary tract - Urothelial cell carcinoma
Upper urinary tract - Urothelial cell carcinoma
GovtRoyapettahHospit
 
Penis carcinoma- management- nonsurgical
Penis  carcinoma- management- nonsurgicalPenis  carcinoma- management- nonsurgical
Penis carcinoma- management- nonsurgical
GovtRoyapettahHospit
 
Prostate carcinoma- focal therapy
Prostate  carcinoma- focal therapyProstate  carcinoma- focal therapy
Prostate carcinoma- focal therapy
GovtRoyapettahHospit
 
Penis carcinoma- surgery- iln mgt
Penis  carcinoma- surgery- iln mgtPenis  carcinoma- surgery- iln mgt
Penis carcinoma- surgery- iln mgt
GovtRoyapettahHospit
 
NMIBC Urianary Bladder Malignancy
NMIBC Urianary Bladder MalignancyNMIBC Urianary Bladder Malignancy
NMIBC Urianary Bladder Malignancy
GovtRoyapettahHospit
 
Testis carcinoma- management- nsgct
Testis  carcinoma- management- nsgctTestis  carcinoma- management- nsgct
Testis carcinoma- management- nsgct
GovtRoyapettahHospit
 
Testis carcinoma- management- seminoma
Testis  carcinoma- management- seminomaTestis  carcinoma- management- seminoma
Testis carcinoma- management- seminoma
GovtRoyapettahHospit
 
Bladder carcinoma- urinary biomarkers diagnosis and staging
Bladder  carcinoma- urinary biomarkers diagnosis and stagingBladder  carcinoma- urinary biomarkers diagnosis and staging
Bladder carcinoma- urinary biomarkers diagnosis and staging
GovtRoyapettahHospit
 
MIBC & Metastatic Urinary Bladder carcinoma
MIBC & Metastatic Urinary Bladder carcinomaMIBC & Metastatic Urinary Bladder carcinoma
MIBC & Metastatic Urinary Bladder carcinoma
GovtRoyapettahHospit
 
Prostate carcinoma- locally advanced
Prostate  carcinoma- locally advancedProstate  carcinoma- locally advanced
Prostate carcinoma- locally advanced
GovtRoyapettahHospit
 
Prostate carcinoma- pathology and staging
Prostate  carcinoma- pathology and stagingProstate  carcinoma- pathology and staging
Prostate carcinoma- pathology and staging
GovtRoyapettahHospit
 
Prostate carcinoma- localised and locally advanced
Prostate  carcinoma- localised and locally advancedProstate  carcinoma- localised and locally advanced
Prostate carcinoma- localised and locally advanced
GovtRoyapettahHospit
 
Prostate carcinoma- imaging
Prostate  carcinoma- imagingProstate  carcinoma- imaging
Prostate carcinoma- imaging
GovtRoyapettahHospit
 
SMALL RENAL MASS
SMALL RENAL MASSSMALL RENAL MASS
SMALL RENAL MASS
GovtRoyapettahHospit
 
Prostate carcinoma- diagnosis and staging
Prostate  carcinoma- diagnosis and stagingProstate  carcinoma- diagnosis and staging
Prostate carcinoma- diagnosis and staging
GovtRoyapettahHospit
 
BENING RENAL TUMORS
BENING RENAL TUMORSBENING RENAL TUMORS
BENING RENAL TUMORS
GovtRoyapettahHospit
 
Rectal carcinoma approach
Rectal carcinoma approachRectal carcinoma approach
Rectal carcinoma approach
Shambhavi Sharma
 
Uro gynacology- radiation f.
Uro gynacology- radiation f.Uro gynacology- radiation f.
Uro gynacology- radiation f.
GovtRoyapettahHospit
 
Prostate carcinoma- biochemical recurremce
Prostate  carcinoma- biochemical recurremceProstate  carcinoma- biochemical recurremce
Prostate carcinoma- biochemical recurremce
GovtRoyapettahHospit
 

Similar to Penis carcinoma- premalignant and management algorithm (20)

Non muscle invasive bladder carcinoma - management
Non muscle invasive bladder carcinoma - managementNon muscle invasive bladder carcinoma - management
Non muscle invasive bladder carcinoma - management
 
Upper urinary tract - Urothelial cell carcinoma
Upper urinary tract - Urothelial cell carcinomaUpper urinary tract - Urothelial cell carcinoma
Upper urinary tract - Urothelial cell carcinoma
 
Penis carcinoma- management- nonsurgical
Penis  carcinoma- management- nonsurgicalPenis  carcinoma- management- nonsurgical
Penis carcinoma- management- nonsurgical
 
Prostate carcinoma- focal therapy
Prostate  carcinoma- focal therapyProstate  carcinoma- focal therapy
Prostate carcinoma- focal therapy
 
Penis carcinoma- surgery- iln mgt
Penis  carcinoma- surgery- iln mgtPenis  carcinoma- surgery- iln mgt
Penis carcinoma- surgery- iln mgt
 
NMIBC Urianary Bladder Malignancy
NMIBC Urianary Bladder MalignancyNMIBC Urianary Bladder Malignancy
NMIBC Urianary Bladder Malignancy
 
Testis carcinoma- management- nsgct
Testis  carcinoma- management- nsgctTestis  carcinoma- management- nsgct
Testis carcinoma- management- nsgct
 
Testis carcinoma- management- seminoma
Testis  carcinoma- management- seminomaTestis  carcinoma- management- seminoma
Testis carcinoma- management- seminoma
 
Bladder carcinoma- urinary biomarkers diagnosis and staging
Bladder  carcinoma- urinary biomarkers diagnosis and stagingBladder  carcinoma- urinary biomarkers diagnosis and staging
Bladder carcinoma- urinary biomarkers diagnosis and staging
 
MIBC & Metastatic Urinary Bladder carcinoma
MIBC & Metastatic Urinary Bladder carcinomaMIBC & Metastatic Urinary Bladder carcinoma
MIBC & Metastatic Urinary Bladder carcinoma
 
Prostate carcinoma- locally advanced
Prostate  carcinoma- locally advancedProstate  carcinoma- locally advanced
Prostate carcinoma- locally advanced
 
Prostate carcinoma- pathology and staging
Prostate  carcinoma- pathology and stagingProstate  carcinoma- pathology and staging
Prostate carcinoma- pathology and staging
 
Prostate carcinoma- localised and locally advanced
Prostate  carcinoma- localised and locally advancedProstate  carcinoma- localised and locally advanced
Prostate carcinoma- localised and locally advanced
 
Prostate carcinoma- imaging
Prostate  carcinoma- imagingProstate  carcinoma- imaging
Prostate carcinoma- imaging
 
SMALL RENAL MASS
SMALL RENAL MASSSMALL RENAL MASS
SMALL RENAL MASS
 
Prostate carcinoma- diagnosis and staging
Prostate  carcinoma- diagnosis and stagingProstate  carcinoma- diagnosis and staging
Prostate carcinoma- diagnosis and staging
 
BENING RENAL TUMORS
BENING RENAL TUMORSBENING RENAL TUMORS
BENING RENAL TUMORS
 
Rectal carcinoma approach
Rectal carcinoma approachRectal carcinoma approach
Rectal carcinoma approach
 
Uro gynacology- radiation f.
Uro gynacology- radiation f.Uro gynacology- radiation f.
Uro gynacology- radiation f.
 
Prostate carcinoma- biochemical recurremce
Prostate  carcinoma- biochemical recurremceProstate  carcinoma- biochemical recurremce
Prostate carcinoma- biochemical recurremce
 

More from GovtRoyapettahHospit

X RAY KUB 1
X RAY KUB 1X RAY KUB 1
X RAY KUB 2
X RAY KUB 2X RAY KUB 2
VOIDING CYSTO URETHROGRAM
VOIDING CYSTO URETHROGRAMVOIDING CYSTO URETHROGRAM
VOIDING CYSTO URETHROGRAM
GovtRoyapettahHospit
 
ULTRASOUND IN UROLOGY
ULTRASOUND IN UROLOGYULTRASOUND IN UROLOGY
ULTRASOUND IN UROLOGY
GovtRoyapettahHospit
 
URODYNAMICS
URODYNAMICSURODYNAMICS
MRI IN UROLOGY
MRI IN UROLOGYMRI IN UROLOGY
MRI IN UROLOGY
GovtRoyapettahHospit
 
INTRAVENOUS UROGRAPHY 1
INTRAVENOUS UROGRAPHY 1INTRAVENOUS UROGRAPHY 1
INTRAVENOUS UROGRAPHY 1
GovtRoyapettahHospit
 
ANTEGRADE URETHROGRAM
ANTEGRADE URETHROGRAMANTEGRADE URETHROGRAM
ANTEGRADE URETHROGRAM
GovtRoyapettahHospit
 
INTRAVENOUS UROGRAPHY
INTRAVENOUS UROGRAPHYINTRAVENOUS UROGRAPHY
INTRAVENOUS UROGRAPHY
GovtRoyapettahHospit
 
Urinary extravasation
Urinary extravasationUrinary extravasation
Urinary extravasation
GovtRoyapettahHospit
 
URODYNAMIC EVALUATION
URODYNAMIC EVALUATIONURODYNAMIC EVALUATION
URODYNAMIC EVALUATION
GovtRoyapettahHospit
 
Tumour markers in urology
Tumour markers in urology Tumour markers in urology
Tumour markers in urology
GovtRoyapettahHospit
 
Transitional urology 1
Transitional urology 1 Transitional urology 1
Transitional urology 1
GovtRoyapettahHospit
 
Retroperitoneal fibrosis
Retroperitoneal fibrosis Retroperitoneal fibrosis
Retroperitoneal fibrosis
GovtRoyapettahHospit
 
URODYNAMICS
URODYNAMICSURODYNAMICS
Urinary obstruction pathophysiology
Urinary obstruction pathophysiologyUrinary obstruction pathophysiology
Urinary obstruction pathophysiology
GovtRoyapettahHospit
 
Uroflowmetry
UroflowmetryUroflowmetry
Uroflowmetry
GovtRoyapettahHospit
 
Pathophysiology of pneumoperitoneum and complications of laproscopic surgery
Pathophysiology of pneumoperitoneum and complications of laproscopic surgeryPathophysiology of pneumoperitoneum and complications of laproscopic surgery
Pathophysiology of pneumoperitoneum and complications of laproscopic surgery
GovtRoyapettahHospit
 
Optics in urology
Optics in urologyOptics in urology
Optics in urology
GovtRoyapettahHospit
 

More from GovtRoyapettahHospit (20)

RENOGRAM
RENOGRAMRENOGRAM
RENOGRAM
 
X RAY KUB 1
X RAY KUB 1X RAY KUB 1
X RAY KUB 1
 
X RAY KUB 2
X RAY KUB 2X RAY KUB 2
X RAY KUB 2
 
VOIDING CYSTO URETHROGRAM
VOIDING CYSTO URETHROGRAMVOIDING CYSTO URETHROGRAM
VOIDING CYSTO URETHROGRAM
 
ULTRASOUND IN UROLOGY
ULTRASOUND IN UROLOGYULTRASOUND IN UROLOGY
ULTRASOUND IN UROLOGY
 
URODYNAMICS
URODYNAMICSURODYNAMICS
URODYNAMICS
 
MRI IN UROLOGY
MRI IN UROLOGYMRI IN UROLOGY
MRI IN UROLOGY
 
INTRAVENOUS UROGRAPHY 1
INTRAVENOUS UROGRAPHY 1INTRAVENOUS UROGRAPHY 1
INTRAVENOUS UROGRAPHY 1
 
ANTEGRADE URETHROGRAM
ANTEGRADE URETHROGRAMANTEGRADE URETHROGRAM
ANTEGRADE URETHROGRAM
 
INTRAVENOUS UROGRAPHY
INTRAVENOUS UROGRAPHYINTRAVENOUS UROGRAPHY
INTRAVENOUS UROGRAPHY
 
Urinary extravasation
Urinary extravasationUrinary extravasation
Urinary extravasation
 
URODYNAMIC EVALUATION
URODYNAMIC EVALUATIONURODYNAMIC EVALUATION
URODYNAMIC EVALUATION
 
Tumour markers in urology
Tumour markers in urology Tumour markers in urology
Tumour markers in urology
 
Transitional urology 1
Transitional urology 1 Transitional urology 1
Transitional urology 1
 
Retroperitoneal fibrosis
Retroperitoneal fibrosis Retroperitoneal fibrosis
Retroperitoneal fibrosis
 
URODYNAMICS
URODYNAMICSURODYNAMICS
URODYNAMICS
 
Urinary obstruction pathophysiology
Urinary obstruction pathophysiologyUrinary obstruction pathophysiology
Urinary obstruction pathophysiology
 
Uroflowmetry
UroflowmetryUroflowmetry
Uroflowmetry
 
Pathophysiology of pneumoperitoneum and complications of laproscopic surgery
Pathophysiology of pneumoperitoneum and complications of laproscopic surgeryPathophysiology of pneumoperitoneum and complications of laproscopic surgery
Pathophysiology of pneumoperitoneum and complications of laproscopic surgery
 
Optics in urology
Optics in urologyOptics in urology
Optics in urology
 

Recently uploaded

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 

Recently uploaded (20)

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 

Penis carcinoma- premalignant and management algorithm

  • 1. PRE-MALIGNANT CONDITIONS AND MANAGEMENTALGORITHM FOR CA. PENIS Dept of Urology Govt Royapettah Hospital and Kilpauk Medical College Chennai 1
  • 2. Moderators: Professors:  Prof. Dr. G. Sivasankar, M.S., M.Ch.,  Prof. Dr.A. Senthilvel, M.S., M.Ch., Asst Professors:  Dr. J. Sivabalan, M.S., M.Ch.,  Dr. R. Bhargavi, M.S., M.Ch.,  Dr. S. Raju, M.S., M.Ch.,  Dr. K. Muthurathinam, M.S., M.Ch.,  Dr. D.Tamilselvan, M.S., M.Ch.,  Dr. K. Senthilkumar, M.S., M.Ch. Dept of Urology, GRH and KMC,Chennai. 2
  • 3. 3 Premalignant Lesions HPV RELATED Related Lesions Cutaneous horns Bowenoid Papulosis Bowen’s Disease Erythroplasia of Queyrat Giant Condylomata Acuminata (Buschke-Lowenstein Tumour) Dept of Urology, GRH and KMC,Chennai.
  • 4. NON HPV RELATED Leukoplakia Pseudoepitheliomatous Micaceous Keratotic Balanitis (PMKB) Balanitis Xerotica Obliterans (Lichen scleorus et Atrophicus) 4 Dept of Urology, GRH and KMC,Chennai.
  • 5. 5 Penile Intraepithelial Neoplasia (PeIN)  Precursor lesion of basaloid & warty penile cancer  HPV infection asso. with all types of PeIN (70-100%)  Basaloid cancer  strongest asso. with HPV (70-100%)  PeIN in males whose female partner has CIN = 33%  Time for malignant progression for low-grade PeIN = 20 yrs World J Urol 2009;27(2):141–50 Urol Clin N Am 2010; 37: 335–32 Dept of Urology, GRH and KMC,Chennai.
  • 6. 6 Bowenoid Papulosis  HPV-related 16 & 18  Average age 30 yrs  Majority (73%) regress or do not recur  Can recur, progress to EQ or BD,or become malignant  Strong relationship with CIN in female sexual partners  Microscopy:spotty distribution of atypical cells & greater maturation of keratinocytes  Risk factors for malignant progression ◦ Smoking, immune suppression, high-risk HPV types, genetics Dept of Urology, GRH and KMC,Chennai.
  • 7. 7 Bowen’s Disease/Erythroplasia of Queyrat  EQ= glans, prepuce  BD= Hair bearing region of genitalia/shaft of penis.  Both histologically similar- correspond toTis  Clearly documented as precursors of invasive penile carcinoma = 10% risk Dept of Urology, GRH and KMC,Chennai.
  • 8. 8 Lichen Sclerosis et Atrophicus (BXO)  Whitish patch on prepuce/glans often involving meatus  Granular erosions,fissures, meatal stenosis, painful erections, urinary obstruction  Uncircumcised middle age men  Microscopy: ◦ Atrophy of squamous epithelium, loss of rete pegs, homogenisation of collagen in upper 1/3rd of dermis  Clobetasol propionate (0.05% , 8–12 wks) Dept of Urology, GRH and KMC,Chennai.
  • 9. 9 Giant Condyloma Accuminata  Buschke-LowensteinTumour  Locally invasive; displaces, invades & destroys adjacent structures by compression  No metastasis  LN mets: Rare => malignant degn  Excision/total Penectomy  Topical 5FU, podophyllin, Bleomycin  RT – ineffective & contraindicated  Malignant Degeneration Dept of Urology, GRH and KMC,Chennai.
  • 10. 10 Verrucous Carcinoma •Is an exuberant variant of sq. cell carcinoma •Low malignant potential •Rarely metastasize to lymphnode •Good prognosis Dept of Urology, GRH and KMC,Chennai.
  • 11. 11 Cutaneous Horn - Overgrowth & Cornification over preexisting skin lesions - Asso with HPV 16 -May evolve into Cancer or develop in an underlying Cancer - Surgical Excision Pseudo epitheliomatous keratotic & micaceous balanitis (PKMB) - Microscopically mimics verrucous Cancer - Cryotherapy,laser, excision - Fibro sarcoma of glans post Cryotherapy Dept of Urology, GRH and KMC,Chennai.
  • 12. Leukoplakia •Solitary or multiple whitish plaques •Involving glans, prepuce, meatus •Asso.withTis and Ta - Surgical Excision 12 Dept of Urology, GRH and KMC,Chennai.
  • 13. 13 Lesions with No malignant Potential  Pearly penile papules  Hirsute papillomas  Coronal Papillae  Zoon’s Balanitis  Benign pigmented warts  Seborrheic keratosis  Lichen planus  Psoriasis  Eczema  Contact dermatitis Dept of Urology, GRH and KMC,Chennai.
  • 14. 14 Treatment of Premalignant lesions eradicate disease while limiting penile mutilation  TopicalTreatment: (Recurrence:13–19%) ◦ Podophyllotoxin, 5 - FU,Imiquimod, Corticosteroids,Trichloracetic acid  Ablative treatments: ◦ Cryosurgery (Recurrence:21%) ◦ Electro surgery ◦ Laser - Nd-YAG, KTP 532, CO2 Lasers (Recurrence:0 -33%) Dept of Urology, GRH and KMC,Chennai.
  • 15. ExcisionalTreatments: (Recurrence 13-33%) Excision Biopsy Moh’s Micrographic Surgery Excision + total glans resurfacing Radiotherapy/ IFNs 15 Dept of Urology, GRH and KMC,Chennai.
  • 16. 16 Treatment of Premalignant lesions Urology 2010;76 (Suppl 2A): S24 –S35 Dept of Urology, GRH and KMC,Chennai.
  • 17. 17 Histopathology  Histologic evaluation – “ is Must”  Wedge biopsy is preferable for diagnosis ◦ Histologic type & grade ◦ Depth of invasion ◦ Vascular invasion ◦ Treatment decisions & Prognosis - preferably based on resected specimen  Good pathology report ◦ Anatomic site, tumor size, histologic type or subtype ◦ Grade, growth pattern ◦ Depth of invasion, tumor thickness, resection margins ◦ Lympho vascular invasion, perineural invasion Dept of Urology, GRH and KMC,Chennai.
  • 18. 18 Ca. Penis Management of Primary Organ Conservation Standard Surgical Procedures Partial penectomy Total penectomy Emasculation Dept of Urology, GRH and KMC,Chennai.
  • 19. Organ Conserving Surgical Approach  LaserTherapy  Mohs Micrographic Surgery  Conservative Local Surgical Excision ◦ Circumcision ◦ Local excision ◦ Total glansectomy 19 Dept of Urology, GRH and KMC,Chennai.
  • 20. LaserTherapy  Lasers used   carbon dioxide (CO2),  neodymium:yttrium-aluminum-garnet (Nd:YAG)  potassium titanyl phosphate (KTP)  Drawbacks ◦ Healing time - 5 to 8 weeks for CO2 laser (8 to 12 weeks for the Nd :YAG and KTP lasers) ◦ local recurrence rate – 20% ◦ difficulty in determining depth of laser coagulation ◦ inability to treat larger lesions ◦ careful long-term surveillance 20 Dept of Urology, GRH and KMC,Chennai.
  • 21. Mohs Micrographic Surgery  removal of cancer by excision of tissue in thin layers  Local control rate - 94%  Best suited in- Ca.in situ, smallT1 21 Dept of Urology, GRH and KMC,Chennai.
  • 22. Local excision  excision of lesion with negative margin  Reconstruction  primary closure,  preputial skin flap,  full-thickness graft of penile skin ,  SSG  local recurrence - 8% to 11% 22 Dept of Urology, GRH and KMC,Chennai.
  • 23. Treatment of Primary lesion-Ta  Laser Excision  Mohs Micrographic Surgery  RT - contraindicated 23 Dept of Urology, GRH and KMC,Chennai.
  • 24. Treatment of Primary lesion- Options  T1,T2,T3  ◦ Partial penectomy ◦ Total penectomy ◦ Emasculation 24 Dept of Urology, GRH and KMC,Chennai.
  • 25. Treatment of Primary lesion- Options  T4 ◦ Emasculation ◦ Hemipelvectomy 25 Dept of Urology, GRH and KMC,Chennai.
  • 26. Penile Cancer Predictors of lymph node metastases  Tumour histology  Corporal invasion  Urethral involvement  Tumour grade  Lymphatic & vascular invasion  DNA ploidy 26 Dept of Urology, GRH and KMC,Chennai.
  • 27. MANAGEMENT OF INGUINAL NODES CA.PENIS SURGERY IF PALPABLE NODES ANTIBIOTICS (4-6WEEKS) 27 Dept of Urology, GRH and KMC,Chennai.
  • 28. NODES NOT PALPABLE NODES PALPABLE PRIMARY – WELL-DIFF NODAL METS OBSERVE ILIO-INGUINAL BLOCK DISSECTION IF PRIMARY MOD/POOR DIFF SUPERFICIAL LND NODE NEG – OBSERVE IF NODE POSITIVE 28 Dept of Urology, GRH and KMC,Chennai.
  • 29. Radiation Therapy for the Primary Lesion  Indications ◦ young patients with small (2- to 4-cm) superficial lesions of distal penis, not willing for amputation ◦ patients who refuse surgery ◦ patients with inoperable cancer ◦ Patients unsuitable for major surgery. 29 Dept of Urology, GRH and KMC,Chennai.
  • 30. Radiation Therapy for the Primary Lesion  EBRT  ◦ direct field method - only for very superficial tumors (Tis ,T1) ◦ parallel opposed field method - T2,T3 (penis irradiated by encasing the lesion in a wax mold)  Brachytherapy  ◦ Interstitial brachytherapy - placement of radioactive material within the tumor ◦ Plesiobrachytherapy- placement of radioactive material molded around the tumor 30 Dept of Urology, GRH and KMC,Chennai.
  • 31. Brachytherapy not suitable  bulky tumors  obese patients with short penis  deeply infiltrating tumors 31 Dept of Urology, GRH and KMC,Chennai.
  • 32. Radiation Therapy for the Primary Lesion  60 Gy to 74 Gy  Salvage penectomy ◦ persistent or recurrent disease after RT ◦ radiation necrosis 32 Dept of Urology, GRH and KMC,Chennai.
  • 33. Although cosmetically attractive, disadvantages are ◦ Useful only in early stage (T1,T2) ◦ Only 65-80% success rate even in early stage ◦ Penile necrosis - 0% to 23% ◦ High chance for stricture urethra ◦ Penectomy required for recurrence and necrosis 33 Dept of Urology, GRH and KMC,Chennai.
  • 34. Role of radiotherapy  Radiation to the inguinal area is not as effective as surgery for treatment of the inguinal nodes.  Prophylactic radiation therapy has not been shown to alter the natural history of inguinal metastases and is not recommended.  Integration of radiation therapy with surgery and chemotherapy in advanced disease requires further study.  Palliative radiation therapy among patients with inoperable inguinal nodes may provide some benefit. 34 Dept of Urology, GRH and KMC,Chennai.
  • 35. Relative Indications for adjuvant therapy- Chemotherapy, RT  >2 metastatic inguinal nodes  Extranodal extension of disease  Pelvic lymph node metastases 35 Dept of Urology, GRH and KMC,Chennai.
  • 36. 36 Inguinal Nodes- Surgical Staging Nomograms to predict inguinal LNM KATTAN, FICCARO ETAL. ◦ tumor thickness, ◦ microscopic growth pattern, ◦ histologic grade, ◦ Vascular embolization, ◦ lymphatic embolization, ◦ infiltration of corpora cavernosa, ◦ corpus spongiosum, or urethra,& ◦ clinical stage of inguinal lymph nodes Dept of Urology, GRH and KMC,Chennai.
  • 37. ThankYou 37 Dept of Urology, GRH and KMC,Chennai.